Event-Driven Stocks

NEPHROS INC

NEPHNasdaq

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 5 good● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$18.8M$14.2M$14.2M$10.0M$10.2M$8.6M
Operating income$1.1M$6,000−$1.6M−$4.3M−$3.3M−$4.3M
Net income$1.2M$74,000−$1.6M−$7.1M−$3.9M−$4.5M
Total assets$13.6M$11.2M$11.9M$11.0M$17.6M$18.5M
Total liabilities$3.4M$2.6M$3.5M$2.1M$2.9M$2.9M
Equity$10.2M$8.6M$8.4M$5.6M$11.7M$12.5M
EPS (diluted)$0.11$0.01$-0.15$-0.73$-0.41—
Shares out.10.6M10.5M10.5M10.3M9.9M9.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
6.1%
Net margin
6.4%
Return on equity
11.7%
Return on assets
8.8%
Return on capital (ROCE)
10.5%
Liabilities / assets
25.2%
Debt / equity
0.34×
Book value / share
$0.96
Revenue growth (YoY)
32.7%
Net income growth (YoY)
1513.5%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-26.46distress
Accruals / assets
−3.3%clean
Beneish M-Score
-2.48normal
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
82
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 5 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202621,1911.0-28.9%
Apr 30, 202629,8111.2-28.1%
Apr 15, 202641,4921.9-11.1%
Mar 31, 202646,6671.0+762.0%
Mar 13, 20265,4141.0+28.8%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.